This site has been blocked by the network administrator. 2007, there have been significant changes that prompted this updated statement. Infection prevention and control is an integral part of pediatric practice in ashrae standard 70 2006 pdf medical settings as well as in hospitals.
Infection prevention and control practices should begin at the time the ambulatory visit is scheduled. All health care personnel should be educated regarding the routes of transmission and techniques used to prevent the transmission of infectious agents. Policies for infection prevention and control should be written, readily available, updated every 2 years, and enforced. Many of the recommendations for infection control and prevention from the Centers for Disease Control and Prevention for hospitalized patients are also applicable in the ambulatory setting.
These recommendations include requirements for pediatricians to take precautions to identify and protect employees likely to be exposed to blood or other potentially infectious materials while on the job. In addition to emphasizing the key principles of infection prevention and control in this policy, we update those that are relevant to the ambulatory care patient. These guidelines emphasize the role of hand hygiene and the implementation of diagnosis- and syndrome-specific isolation precautions, with the exemption of the use of gloves for routine diaper changes and wiping a well child’s nose or tears for most patient encounters. Lastly, in this policy, we emphasize the importance of public health interventions, including vaccination for patients and health care personnel, and outline the responsibilities of the health care provider related to prompt public health notification for specific reportable diseases and communication with colleagues who may be providing subsequent care of an infected patient to optimize the use of isolation precautions and limit the spread of contagions. Guidelines for environmental infection control in health-care facilities. Community interventions to promote healthy social environments: early childhood development and family housing.
A report on recommendations of the Task Force on Community Preventive Services. Guidelines for the prevention of intravascular catheter-related infections. Evaluation of transmission of Mycobacterium tuberculosis in a pediatric setting. Viral hepatitis transmission in ambulatory health care settings. Hepatitis C transmission due to contamination of multidose medication vials: summary of an outbreak and a call to action. A large outbreak of hepatitis B virus infections associated with frequent injections at a physician’s office. Preventing and controlling tuberculosis along the U.
Infection prevention in the emergency department. Rotavirus outbreak on a pediatric oncology floor: possible association with toys. Toys in a pediatric hospital: are they a bacterial source? Viral contamination of environmental surfaces on a general paediatric ward and playroom in a major referral centre in Riyadh. Examination gloves as barriers to hand contamination in clinical practice. Strategies to prevent healthcare-associated infections through hand hygiene. Use of alcohol-based hand sanitizers as a risk factor for norovirus outbreaks in long-term care facilities in northern New England: December 2006 to March 2007.
Consumer antibacterial soaps: effective or just risky? Efficiency of surgical masks in use in hospital wards. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.
Infection prevention and control guideline for cystic fibrosis: 2013 update. An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis. A 1-m distance is not safe for children with cystic fibrosis at risk for cross-infection with Pseudomonas aeruginosa. Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis.